The primary outcome measure is normalized T1-weighted signal intensity. One month after injection [clinicaltrials_resource:774286cceed3b1e017099df5c5e5be42]
Contrast Agent
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The primary outcome measure is normalized T1-weighted signal intensity. One month after injection [clinicaltrials_resource:774286cceed3b1e017099df5c5e5be42]
Contrast Agent
Bio2RDF identifier
774286cceed3b1e017099df5c5e5be42
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:774286cceed3b1e017099df5c5e5be42
measure [clinicaltrials_vocabulary:measure]
The primary outcome measure is normalized T1-weighted signal intensity.
time frame [clinicaltrials_vocabulary:time-frame]
One month after injection
description
Contrast Agent
identifier
clinicaltrials_resource:774286cceed3b1e017099df5c5e5be42
title
The primary outcome measure is ...... ity. One month after injection
@en
type
label
The primary outcome measure is ...... 286cceed3b1e017099df5c5e5be42]
@en